Investing.com -- C3.ai shares plunged more than 31% premarket Monday after the software maker posted preliminary fiscal first ...

Investing.com -- ZIM Integrated Shipping (NYSE: ZIM) stock surged 20% in premarket trading Monday following reports that CEO ...

“Restaurant stocks look broken right now,” a team led by Dennis Geiger, wrote, noting that both softer and in some cases good ...

Investing.com -- Viatris Inc (NASDAQ: VTRS) stock rose 2.6% following the U.S. Food and Drug Administration’s approval of the company’s Iron Sucrose Injection, USP, the first generic version of ...

VivoPower will become the first publicly listed company in the United States providing shareholders with exposure to both Ripple shares and XRP tokens. The company will have full legal title to the ...

Investing.com -- Amphastar Pharmaceuticals (NASDAQ: AMPH) stock gained 4% after the company announced FDA approval for its generic version of iron sucrose injection, a treatment for iron deficiency ...

Investing.com -- Nyxoah SA (BR:NYXH) (NASDAQ: NYXH) stock jumped 9.4% following FDA approval of its Genio system for treating moderate to severe obstructive sleep apnea (OSA).

Investing.com -- IO Biotech (NASDAQ: IOBT) stock rose 6.1% after announcing topline results from its pivotal Phase 3 trial of Cylembio, an investigational cancer vaccine, in combination with Merck ...

Following the suspension, VSee’s common stock and warrants will transition to trading on the OTC Markets system under the same symbols "VSEE" and "VSEEW," respectively. The company plans to appeal the ...

Intel (NASDAQ: INTC) stock rose 3% Monday morning, paring recent declines as CEO Lip-Bu Tan prepares for a White House meeting following President Trump’s deman ...

S&P expects Kering’s revenue to reach €14.8 billion-€15.0 billion for fiscal year 2025, with adjusted EBITDA of €3.6 billion-€3.7 billion, down from €4.5 billion in 2024. The company’s projected 2025 ...

Investing.com -- Jefferies downgraded digital advertising platform The Trade Desk (NASDAQ: TTD) to Hold from Buy given a sharper-than-expected slowdown in revenue growth amid growing competition and ...